School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Curtis Henry

  • Department of Pediatrics
    Assistant Professor
  • curtis.j.henry@emory.edu
  • Emory/ Winship Cancer Institute
  • Aflac Cancer and Blood Disorders Center
    Pediatrics
    2015 Uppergate Drive
Head shot of Curtis Henry

Academic Appointment

  • Assistant Professor, Pediatrics, Emory University

Education

Degrees

  • PhD, Immunology from Wake Forest University, Winston-Salem
  • BS from Florida Agricultural and Mechanical University, Tallahassee

Research

Publications

  • MERTK inhibition selectively activates a DC - T-cell axis to provide anti-leukemia immunity.
    Leukemia Volume: 38 Page(s): 2685 - 2698
    12/01/2024 Authors: Huelse JM; Bhasin SS; Jacobsen KM; Yim J; Thomas BE; Branella GM; Bakhtiari M; Chimenti ML; Baxter TA; Raikar SS
  • Pharmacological suppression of the OTUD4/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancers.
    J Clin Invest Volume: 134
    03/26/2024 Authors: Zhu Y; Banerjee A; Xie P; Ivanov AA; Uddin A; Jiao Q; Chi JJ; Zeng L; Lee JY; Xue Y
  • The Epigenetic Landscape of Breast Cancer, Metabolism, and Obesity.
    Adv Exp Med Biol Volume: 1465 Page(s): 37 - 53
    01/01/2024 Authors: Townsel A; Jaffe M; Wu Y; Henry CJ; Haynes KA
  • Early B-cell development and B-cell maturation are impaired in patients with active hemophagocytic lymphohistiocytosis.
    Volume: 142 Page(s): 1972 - 1984
    12/07/2023 Authors: Shim J; Park S; Venkateswaran S; Kumar D; Prince C; Parihar V; Maples L; Waller EK; Kugathasan S; Briones M
  • A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors.
    Volume: 70 Page(s): e30405
    08/01/2023 Authors: Cash T; Jonus HC; Tsvetkova M; Beumer JH; Sadanand A; Lee JY; Henry CJ; Aguilera D; Harvey RD; Goldsmith KC
  • Siglec-15 Promotes Evasion of Adaptive Immunity in B-cell Acute Lymphoblastic Leukemia.
    Cancer Res Commun Volume: 3 Page(s): 1248 - 1259
    07/01/2023 Authors: Pillsbury CE; Dougan J; Rabe JL; Fonseca JA; Zhou C; Evans AN; Abukharma H; Ichoku O; Gonzalez-Flamenco G; Park SI
  • Sex, aging, immunity and adrenal cancer.
    Nat Aging Volume: 3 Page(s): 764 - 765
    07/01/2023 Authors: Townsel A; Henry CJ
  • The 'omics of obesity in B-cell acute lymphoblastic leukemia.
    J Natl Cancer Inst Monogr Volume: 2023 Page(s): 12 - 29
    05/04/2023 Authors: Geitgey DK; Lee M; Cottrill KA; Jaffe M; Pilcher W; Bhasin S; Randall J; Ross AJ; Salemi M; Castillo-Castrejon M
  • Multicolor Light-Induced Immune Activation via Polymer Photocaged Cytokines.
    Biomacromolecules Volume: 24 Page(s): 1164 - 1172
    03/13/2023 Authors: Birnbaum LA; Sullivan EC; Do P; Uricoli B; Raikar SS; Porter CC; Henry CJ; Dreaden EC
  • B-cell acute lymphoblastic leukemia promotes an immune suppressive microenvironment that can be overcome by IL-12.
    Sci Rep Volume: 12 Page(s): 11870
    07/13/2022 Authors: Hunter R; Imbach KJ; Zhou C; Dougan J; Hamilton JAG; Chen KZ; Do P; Townsel A; Gibson G; Dreaden EC
  • Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia.
    Nat Commun Volume: 13 Page(s): 1157
    03/03/2022 Authors: Lee M; Hamilton JAG; Talekar GR; Ross AJ; Michael L; Rupji M; Dwivedi B; Raikar SS; Boss J; Scharer CD
  • Adipocyte-mediated epigenomic instability in human T-ALL cells is cytotoxic and phenocopied by epigenetic-modifying drugs.
    Front Cell Dev Biol Volume: 10 Page(s): 909557
    01/01/2022 Authors: Lee M; Geitgey DK; Hamilton JAG; Boss JM; Scharer CD; Spangle JM; Haynes KA; Henry CJ
  • Germline ETV6 mutation promotes inflammation and disrupts lymphoid development of early hematopoietic progenitors.
    Exp Hematol Volume: 112-113 Page(s): 24 - 34
    01/01/2022 Authors: Zhou C; Uluisik R; Rowley JW; David C; Jones CL; Scharer CD; Noetzli L; Fisher MH; Kirkpatrick GD; Bark K
  • OBESITY ATTENUTATES T-CELL FUNCTION WHICH IMPACTS T-CELL IMMUNOTHERAPIES IN LYMPHOBLASTIC LEUKEMIA
    Volume: 68 Page(s): S5 - S5
    06/01/2021 Authors: Ross A; Ank R; Lee M; Hamilton J; Story J; Raikar S; Do P; Porter C; Henry C
  • IL-412 abrogates mechanisms of immune suppression by B-ALL
    Volume: 206
    05/01/2021 Authors: Hunter R; Henry CJ; Porter C
  • Adipocyte-secreted Interleukin-9 Promotes Leukemia Development and Chemoresistance to Front-line Chemotherapies
    Volume: 206
    05/01/2021 Authors: Hamilton JAG; Pillsbury CE; Lee M; Henry CJ
  • Obese microenvironments attenuate the efficacy of endogenous and CD19-directed CAR T-cells
    Volume: 206
    05/01/2021 Authors: Ank RS; Henry CJ
  • Interleukin-37 improves T-cell-mediated immunity and chimeric antigen receptor T-cell therapy in aged backgrounds.
    Aging Cell Volume: 20 Page(s): e13309
    02/01/2021 Authors: Hamilton JAG; Lee MY; Hunter R; Ank RS; Story JY; Talekar G; Sisroe T; Ballak DB; Fedanov A; Porter CC
  • Talin-dependent integrin activation is required for endothelial proliferation and postnatal angiogenesis.
    Angiogenesis Volume: 24 Page(s): 177 - 190
    02/01/2021 Authors: Pulous FE; Carnevale JC; Al-Yafeai Z; Pearson BH; Hamilton JAG; Henry CJ; Orr AW; Petrich BG
  • MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity.
    JCI Insight Volume: 5
    12/03/2020 Authors: Lee-Sherick AB; Jacobsen KM; Henry CJ; Huey MG; Parker RE; Page LS; Hill AA; Wang X; Frye SV; Earp HS
  • Aging and immunotherapies: New horizons for the golden ages.
    Aging Cancer Volume: 1 Page(s): 30 - 44
    12/01/2020 Authors: Hamilton JAG; Henry CJ
  • Single Cell Transcriptomics Revealed AML and Non-AML Cell Clusters Relevant to Relapse and Remission in Pediatric AML
    Volume: 136
    11/05/2020 Authors: Thomas BE; Perumalla P; Bhasin SS; Sarkar D; Dwivedi B; Park SI; DeRyckere D; Henry CJ; Raikar SS; Porter CC
  • Obesity Attenuates T-Cell Function Which Impacts the Efficacy of T-Cell Based Immunotherapies in Acute Lymphoblastic Leukemia
    Volume: 136
    11/05/2020 Authors: Ross A; Lee M; Hamilton J; Ank R; Do P; Story J; Raikar SS; Dreaden E; Porter CC; Henry CJ
  • Obesity-Induced Chemoresistance in B-Cell Acute Lymphoblastic Leukemia Cells Is Mediated By Reduced Chemotherapy Uptake and Interleukin-9 Signaling
    Volume: 136
    11/05/2020 Authors: Hamilton JAG; Lee M; Talekar GR; Henry CJ
  • Rapid Assembly and Screening of Multivalent Immune Cell-Redirecting Therapies for Leukemia.
    ACS Comb Sci Volume: 22 Page(s): 533 - 541
    10/12/2020 Authors: Do P; Perdue LA; Chyong A; Hunter R; Dougan J; Henry CJ; Porter CC; Dreaden EC
  • OBESITY IMPAIRS T-CELL FUNCTION WHICH MAY IMPACT THE EFFICACY OF CAR T-CELLS IN PEDIATRIC LEUKEMIA
    Volume: 67 Page(s): S5 - S6
    06/01/2020 Authors: Ross A; Lee M; Hamilton J; Talekar G; Henry C; Raikar S; Story J
  • Consumption of Diet Soda Sweetened with Sucralose and Acesulfame-Potassium Alters Inflammatory Transcriptome Pathways in Females with Overweight and Obesity.
    Mol Nutr Food Res Volume: 64 Page(s): e1901166
    06/01/2020 Authors: Sylvetsky AC; Sen S; Merkel P; Dore F; Stern DB; Henry CJ; Cai H; Walter PJ; Crandall KA; Rother KI
  • Promoting anti-tumor immunity via bispecific T cell engaging cytokine (biteokine) therapy
    Volume: 204
    05/01/2020 Authors: Do P; Perdue LA; Chyong A; Henry CJ; Porter CC; Dreaden EC
  • Innate immune populations contribute to effective immune responses against B lymphoblastic leukemia cells
    Volume: 204
    05/01/2020 Authors: Hunter R; Henry CJ; Porter CC
  • Elevated Levels of Interleukin-9 in Obese Microenvironments Promote Leukemia Progression and Chemoresistance in B-Cell Acute Lymphoblastic Leukemia Cells
    Volume: 134
    11/13/2019 Authors: Hamilton JAG; Lee M; Talekar GR; Henry CJ
  • IL12 Abrogates Calcineurin-Dependent Immune Evasion during Leukemia Progression.
    Cancer Res Volume: 79 Page(s): 3702 - 3713
    07/15/2019 Authors: Rabe JL; Gardner L; Hunter R; Fonseca JA; Dougan J; Gearheart CM; Leibowitz MS; Lee-Miller C; Baturin D; Fosmire SP
  • Adipocyte-secreted proteins induce DNA damage and apoptosis in T-cell acute lymphoblastic leukemia
    Volume: 79
    07/01/2019 Authors: Lee M; Henry CJ
  • Calcineurin represses IL-12 secretion in acute lymphoblastic leukemia
    Volume: 79
    07/01/2019 Authors: Hunter R; Fonseca J; Dougan J; Gardner LA; Rabe J; Rupji M; Dwivedi B; Henry CJ; Porter CC
  • DELINEATING THE ROLE OF OBESITY IN IMMUNOTHERAPY EFFICACY IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
    Volume: 66
    06/01/2019 Authors: Ross A; Hamilton J; Lee M; Talekar G; Henry C
  • Interleukin-37 improves aging-associated declines in adaptive immunity leading to enhanced suppression of Ph plus leukemia
    Volume: 202
    05/01/2019 Authors: Henry CJ; Eisenmesser E; Dinarello CA; DeGregori J
  • MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity.
    JCI Insight Volume: 3
    11/02/2018 Authors: Lee-Sherick AB; Jacobsen KM; Henry CJ; Huey MG; Parker RE; Page LS; Hill AA; Wang X; Frye SV; Earp HS
  • Proliferative and Invasive Colorectal Tumors in Pet Dogs Provide Unique Insights into Human Colorectal Cancer.
    Cancers (Basel) Volume: 10
    09/14/2018 Authors: Wang J; Wang T; Sun Y; Feng Y; Kisseberth WC; Henry CJ; Mok I; Lana SE; Dobbin K; Northrup N
  • OLT1177, a -sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation.
    Proc Natl Acad Sci U S A Volume: 115 Page(s): E1530 - E1539
    02/13/2018 Authors: Marchetti C; Swartzwelter B; Gamboni F; Neff CP; Richter K; Azam T; Carta S; Tengesdal I; Nemkov T; D'Alessandro A
  • Folate dietary insufficiency and folic acid supplementation similarly impair metabolism and compromise hematopoiesis.
    Haematologica Volume: 102 Page(s): 1985 - 1994
    12/01/2017 Authors: Henry CJ; Nemkov T; Cass-Selves M; Bilousova G; Zaberezhnyy V; Higa KC; Serkova NJ; Hansen KC; D'Alessandro A; DeGregori J
  • Aging-associated inflammation promotes selection for adaptive oncogenic events in B cell progenitors.
    J Clin Invest Volume: 125 Page(s): 4666 - 4680
    12/01/2015 Authors: Henry CJ; Cass-Selves M; Kim J; Zaberezhnyy V; Aghili L; Daniel AE; Jimenez L; Azam T; McNamee EN; Clambey ET
  • Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenoma.
    BMC Cancer Volume: 15 Page(s): 123
    03/14/2015 Authors: Henry CJ; Sedjo RL; Rozhok A; Salstrom J; Ahnen D; Levin TR; D'Agostino R; Haffner S; DeGregori J; Byers T
  • Bcr-Abl expression overcomes aging-associated functional declines in B-Lymphopoiesis leading to increased leukemogenesis
    Volume: 190
    05/01/2013 Authors: Henry C; Marusyk A; Zaberezhnyy V; Casas M; Serkova N; Clambey E; DeGregori J
  • Extracellular cyclophilin-A stimulates ERK1/2 phosphorylation in a cell-dependent manner but broadly stimulates nuclear factor kappa B.
    Cancer Cell Int Volume: 12 Page(s): 19
    07/04/2012 Authors: Bahmed K; Henry C; Holliday M; Redzic J; Ciobanu M; Zhang F; Weekes C; Sclafani R; Degregori J; Eisenmesser E
  • Aging-associated changes in hematopoiesis and leukemogenesis: what's the connection?
    Aging (Albany NY) Volume: 3 Page(s): 643 - 656
    06/01/2011 Authors: Henry CJ; Marusyk A; DeGregori J
  • Distinct responses of splenic dendritic cell subsets to infection with Listeria monocytogenes: maturation phenotype, level of infection, and T cell priming capacity ex vivo.
    Cell Immunol Volume: 268 Page(s): 79 - 86
    01/01/2011 Authors: Mitchell LM; Brzoza-Lewis KL; Henry CJ; Grayson JM; Westcott MM; Hiltbold EM
  • Declining lymphoid progenitor fitness promotes aging-associated leukemogenesis.
    Proc Natl Acad Sci U S A Volume: 107 Page(s): 21713 - 21718
    12/14/2010 Authors: Henry CJ; Marusyk A; Zaberezhnyy V; Adane B; DeGregori J
  • Dendritic cells inhibit the progression of Listeria monocytogenes intracellular infection by retaining bacteria in major histocompatibility complex class II-rich phagosomes and by limiting cytosolic growth.
    Infect Immun Volume: 78 Page(s): 2956 - 2965
    07/01/2010 Authors: Westcott MM; Henry CJ; Amis JE; Hiltbold EM
  • The roles of IL-12 and IL-23 in CD8+ T cell-mediated immunity against Listeria monocytogenes: Insights from a DC vaccination model.
    Cell Immunol Volume: 264 Page(s): 23 - 31
    01/01/2010 Authors: Henry CJ; Grayson JM; Brzoza-Lewis KL; Mitchell LM; Westcott MM; Cook AS; Hiltbold EM
  • Irradiation alters selection for oncogenic mutations in hematopoietic progenitors.
    Cancer Res Volume: 69 Page(s): 7262 - 7269
    09/15/2009 Authors: Marusyk A; Cass-Selves M; Henry CJ; Zaberezhnyy V; Klawitter J; Christians U; DeGregori J
  • H. influenzae and M. catarrhalis trigger a potent immune response through activation of dendritic cells
    JOURNAL OF IMMUNOLOGY Volume: 182
    04/01/2009 Authors: Dew KE; Henry CJ; Mitchell LM; Hiltbolt EM; Swords WE
  • IL-12 produced by dendritic cells augments CD8+ T cell activation through the production of the chemokines CCL1 and CCL17.
    J Immunol Volume: 181 Page(s): 8576 - 8584
    12/15/2008 Authors: Henry CJ; Ornelles DA; Mitchell LM; Brzoza-Lewis KL; Hiltbold EM
  • Dendritic Cell Produced IL-12 Augments CD8+T cell Activation through the Production of the Chemokines CCL1 and CCL17
    FASEB JOURNAL Volume: 22
    04/01/2008 Authors: Henry CJ; Grayson JM; Ornelles DA; Brzoza KL; Hiltbold EM
  • Differential susceptibility of bone marrow-derived dendritic cells and macrophages to productive infection with Listeria monocytogenes.
    Cell Microbiol Volume: 9 Page(s): 1397 - 1411
    06/01/2007 Authors: Westcott MM; Henry CJ; Cook AS; Grant KW; Hiltbold EM
  • IL-12/23 Signals Delivered by Dendritic Cells Predominantly Within the First 48 Hours of T cell Priming Dictates the Functional Capacity of CTLs
    JOURNAL OF IMMUNOLOGY Volume: 178
    04/01/2007 Authors: Henry CJ; Grayson JM; Westcott MM; Brzoza KL; Hiltbold EM
  • IL-12 exerts its effects during the first 48 hours of T cell priming leading to stable conjugate formation and robust INF-[gamma] production
    Volume: 176 Page(s): S13 - S14
    04/01/2006 Authors: Henry CJ; Hiltbold E
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements